Search by Drug Name or NDC

    NDC 42291-0327-01 guanfacine 4 mg/1 Details

    guanfacine 4 mg/1

    guanfacine is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is GUANFACINE HYDROCHLORIDE.

    Product Information

    NDC 42291-0327
    Product ID 42291-327_0e8c5472-74f7-6f18-e063-6294a90a6c04
    Associated GPIs 61353030107550
    GCN Sequence Number 065574
    GCN Sequence Number Description guanfacine HCl TAB ER 24H 4 MG ORAL
    HIC3 H8M
    HIC3 Description TX FOR ADHD - SELECTIVE ALPHA-2 RECEPTOR AGONIST
    GCN 27582
    HICL Sequence Number 000120
    HICL Sequence Number Description GUANFACINE HCL
    Brand/Generic Generic
    Proprietary Name guanfacine
    Proprietary Name Suffix n/a
    Non-Proprietary Name guanfacine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 4
    Active Ingredient Units mg/1
    Substance Name GUANFACINE HYDROCHLORIDE
    Labeler Name AvKARE
    Pharmaceutical Class Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA200881
    Listing Certified Through 2025-12-31

    Package

    NDC 42291-0327-01 (42291032701)

    NDC Package Code 42291-327-01
    Billing NDC 42291032701
    Package 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-327-01)
    Marketing Start Date 2015-07-09
    NDC Exclude Flag N
    Pricing Information N/A